HR 4158
116th Congress
House
CURE High Drug Prices Act
Official title: To prohibit price gouging in the sale of drugs.
Health
Administrative remediesCivil actions and liabilityHealth care costs and insuranceHealth care coverage and access
More subjectsShow fewer subjects
Health programs administration and fundingInflation and pricesPrescription drugs
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 5, 2019
Referred to the Subcommittee on Health.
Aug 2, 2019
Referred to the House Committee on Energy and Commerce.
Aug 2, 2019
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health.
Plain-English summary
Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act
This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.
Related & companion bills
1
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cite this page
U.S. Congress. (2026). H.R. 4158: CURE High Drug Prices Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-4158/
"H.R. 4158: CURE High Drug Prices Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-4158/.
H.R. 4158, 116th Cong. (2026), https://openamerica.io/bill/116-HR-4158/.
[H.R. 4158: CURE High Drug Prices Act](https://openamerica.io/bill/116-HR-4158/)